Study Links Glucosamine Supplement to Faster Cognitive Decline in People With Mild Cognitive Impairment
By
Megan Brooks
Summary
A new study analyzing electronic health records found that glucosamine, a popular joint supplement, was associated with a 25% higher likelihood of progression from mild cognitive impairment (MCI) to dementia over 5 years. Experiments in human brain tissue and mouse models suggest that excessive protein glycosylation may contribute to Alzheimer's disease progression, and glucosamine supplementation could exacerbate this process. The research identifies glycan metabolism as a potential new therapeutic target for Alzheimer's disease.
Source
Key quotes
· 3 pulledGlucosamine use was associated with a 25% higher likelihood of progression from MCI to dementia over 5 years.
Experiments in human brain tissue and mouse models suggested that excessive protein glycosylation may contribute to Alzheimer's disease progression.
Glucosamine supplementation could exacerbate the progression of Alzheimer's disease through excessive protein glycosylation.
You might also wanna read
Creatine supplement shows cognitive benefits: slows early Alzheimer's decline by 30% and improves mental performance, studies find
A comprehensive review (2025) and clinical trial (2026) reveal that creatine, widely used as a muscle-building supplement, also crosses the
thesciverse.org·20d ago
High-dose DHA supplementation reaches brain targets but fails to improve cognition or brain structure in older adults at risk for dementia
This phase IIa randomized controlled trial investigated high-dose DHA supplementation (2g/day) over 24 months in non-demented older adults (
Hyperglycosylation is a metabolic driver of Alzheimer’s disease - Nature Metabolism
Lifestyle Changes Like Exercise and Diet Can Slow Cognitive Decline in Older Adults, Study Finds
A clinical trial involving 2,100 participants suggests that structured and self-guided lifestyle changes, including regular exercise, diet,
Long-term study links moderate coffee and tea consumption to 18% lower dementia risk
A long-term study tracking over 130,000 people for four decades found that regular consumption of moderate amounts of caffeinated coffee or

Monash University study finds copper-delivering drug Cu(ATSM) reduces Alzheimer's proteins and improves memory in lab tests
Monash University researchers have discovered that a copper-delivering drug called Cu(ATSM) significantly reduces toxic Alzheimer's proteins
